ArticleInternational urology and nephrology2026
An international public-private partnership model for kidney replacement therapy in Uzbekistan: lessons and challenges.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeUzbekistan is an independent country in Central Asia, with a population of 35.6 million and a GDP per capita of $2254. There is a growing need for affordable kidney replacement therapy in the country.
methodsA public-private partnership was established between the Uzbekistan government and a large private hemodialysis provider to enhance access to high-quality, safe, and effective maintenance hemodialysis. We describe the hemodialysis service delivery model, resources, and services, and also the demographics of the patient population, dialysis practices, and programme outcomes from 2022 to December 2024.
findingsIn the first phase, hemodialysis facilities were established in three cities: Bogot, Nukus, and Urgench and later in Tashkent. The HD technician/nurse-to-patient ratio was 1:4. Nephrology-trained physicians managed hemodialysis and provided overall supervision. Approximately 46% of patients were between 41 and 60 years old, 58% were male, and 51% had a high school education level. The most common cause of chronic kidney disease was glomerulonephritis (44%). 70% had a functioning arteriovenous fistula, 32% were on three times weekly dialysis, 16% were Hepatitis C positive. Mean follow-up was 351 days. The outcomes were: 26% died, 6% went for a kidney transplant and 47% continued hemodialysis at the same centre. Government hospitals provide support for acute care and biochemical monitoring. DISCUSSION: This project showcases an innovative model for delivering hemodialysis care in Uzbekistan, highlighting how the private sector can contribute to closing gaps in healthcare delivery services.
Indexed as
Identifiers
41712035What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.